LabCorp Appoints Senior Finance Executive Jeffrey A. Davis to Its Board of Directors
Current CFO of
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005484/en/
“With more than 30 years of finance experience, including senior roles at some of the world’s most recognizable companies, Jeff brings a wealth of experience across a highly relevant range of industries, from healthcare to digital to retail,” said
In addition to his current role as executive vice president and CFO of
“For more than 50 years, LabCorp has been improving health and improving lives,” said Davis. “I am honored to join the board as we set the stage for the company’s next 50 years of success. I look forward to working with my fellow board members,
Davis’ appointment fills the vacancy created when
Davis previously has served on the board of
He has received numerous awards, including the Distinguished Alumnus Award from the Joseph M. Katz
Davis holds a bachelor’s degree in accounting from the
About LabCorp
LabCorp (NYSE: LH), an
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to statements with respect to the Company’s leadership, future operations and opportunities. Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the Company’s control, including without limitation, the performance of employees and executives, the willingness of employees and executives to remain employed, competitive actions and other unforeseen changes and general uncertainties in the marketplace, changes in government regulations, including healthcare reform, customer purchasing decisions, including changes in payer regulations or policies, other adverse actions of governmental and third-party payers, changes in testing guidelines or recommendations, the effect of public opinion on the Company’s reputation, adverse results in material litigation matters, failure to maintain or develop customer relationships, our ability to develop or acquire new products and adapt to technological changes, failure in information technology, systems or data security, adverse weather conditions, and employee relations. These factors, in some cases, have affected and in the future (together with other factors) could affect the Company’s ability to implement the Company’s business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the Company’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the Company’s other filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20191126005484/en/
Source: LabCorp
LabCorp Contacts:
Media: Pattie Kushner — 336-436-8263
[email protected]
Investors: Clarissa Willett — 336-436-5076
[email protected]